circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway
2020 · Molecular Therapy — Nucleic Acids · 41 citations
https://doi.org/10.1016/j.omtn.2020.07.027
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
336
Citations
9
h-index
8
i10-index
Yutang Huang is an academic researcher from National Sun Yat-sen University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 9, co-authored 24 publications.
ORCID: 0009-0000-7220-3411https://doi.org/10.1016/j.omtn.2020.07.027
https://doi.org/10.1038/s41419-022-05014-1
https://doi.org/10.1088/1361-6501/ae46b8
Click to start Chat